Cargando…

Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation

BACKGROUND: Renal dysfunction influences outcomes after pulmonary embolism (PE). We aimed to determine the incremental value of adding renal dysfunction, defined by estimated glomerular filtration rate (eGFR), on top of the European Society of Cardiology (ESC) prognostic model, for the prediction of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chopard, Romain, Jimenez, David, Serzian, Guillaume, Ecarnot, Fiona, Falvo, Nicolas, Kalbacher, Elsa, Bonnet, Benjamin, Capellier, Gilles, Schiele, François, Bertoletti, Laurent, Monreal, Manuel, Meneveau, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874488/ https://www.ncbi.nlm.nih.gov/pubmed/33563311 http://dx.doi.org/10.1186/s13054-021-03458-z

Ejemplares similares

Available Bleeding Scoring Systems Poorly Predict Major Bleeding in the Acute Phase of Pulmonary Embolism
por: Mathonier, Camille, et al.
Publicado: (2021)

An Update on the Management of Acute High-Risk Pulmonary Embolism
por: Chopard, Romain, et al.
Publicado: (2022)

Catheter-directed therapy for acute pulmonary embolism: navigating gaps in the evidence
por: Chopard, Romain, et al.
Publicado: (2019)

Extended Anticoagulation After Pulmonary Embolism: A Multicenter Observational Cohort Analysis
por: Chopard, Romain, et al.
Publicado: (2022)

Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure: protocol for the prospective, observational PFO-AF study
por: Badoz, Marc, et al.
Publicado: (2023)

Microvascular obstruction assessed by 3-tesla magnetic resonance imaging in acute myocardial infarction is correlated with plasma troponin I levels
por: Pernet, Karine, et al.
Publicado: (2014)

End-of-life situations in cardiology: a qualitative study of physicians' and nurses’ experience in a large university hospital
por: Ecarnot, Fiona, et al.
Publicado: (2018)

Clinical significance of optical coherence tomography-guided angioplasty on treatment selection
por: Huang, Jianfeng, et al.
Publicado: (2018)

Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients
por: Mouhat, Basile, et al.
Publicado: (2020)

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study
por: Badoz, Marc, et al.
Publicado: (2021)

Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI
por: Monnin, C, et al.
Publicado: (2021)

Intermediate-Risk Pulmonary Embolism: A Review of Contemporary Diagnosis, Risk Stratification and Management
por: Machanahalli Balakrishna, Akshay, et al.
Publicado: (2022)

Unmet needs in the management of pulmonary embolism: catheter-directed therapy looks set to fill the void
por: Meneveau, Nicolas
Publicado: (2019)

Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial
por: Barco, Stefano, et al.
Publicado: (2018)

Risk-stratification in normotensive acute pulmonary embolism
por: Handoko, M. L., et al.
Publicado: (2014)

Intermediate-High Risk Pulmonary Embolism
por: Mirambeaux, Rosa, et al.
Publicado: (2019)

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Changing biventricular mechanics during thrombectomy for intermediate high-risk pulmonary embolism
por: van den Enden, Antoon J M, et al.
Publicado: (2022)

Pitfalls in Risk Stratification: The Case of Acute Pulmonary Embolism
por: Petretta, Mario, et al.
Publicado: (2023)

PULMONARY EMBOLISM RISK STRATIFICATION IN PATIENTS WITH COVID-19 AND ACUTE PULMONARY EMBOLISM
por: GOLUBYKH, KONSTANTIN, et al.
Publicado: (2022)

Impact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis
por: Besch, Guillaume, et al.
Publicado: (2019)

Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
por: Mavromanoli, Anna C., et al.
Publicado: (2022)

Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial
por: Sanchez, Olivier, et al.
Publicado: (2021)

CRB-65 for Risk Stratification and Prediction of Prognosis in Pulmonary Embolism
por: Keller, Karsten, et al.
Publicado: (2023)

Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism
por: Vuilleumier, Nicolas, et al.
Publicado: (2016)

Does thrombo-aspiration still have a place in the treatment of myocardial infarction?
por: Schiele, François, et al.
Publicado: (2016)

A New Model for Risk Stratification of Patients With Acute Pulmonary Embolism
por: Jen, Wei-Ying, et al.
Publicado: (2018)

High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism
por: Ebner, Matthias, et al.
Publicado: (2020)

Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives
por: Leidi, Antonio, et al.
Publicado: (2022)

Intermediate-risk pulmonary embolism: echocardiography predictors of clinical deterioration
por: Weekes, Anthony J., et al.
Publicado: (2022)

Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)

Electrocardiography Patterns and the Role of the Electrocardiography Score for Risk Stratification in Acute Pulmonary Embolism
por: Ryu, Hyeon Min, et al.
Publicado: (2010)

Cell-free DNA as a promising marker for risk stratification of pulmonary embolism
por: Neto-Neves, Evandro M
Publicado: (2013)

Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients
por: Corrigan, Daniel, et al.
Publicado: (2016)

Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
por: Merrick, Gregory S., et al.
Publicado: (2015)

Cardiovascular Ultrasound in the Diagnosis and Management of Acute Intermediate-Risk Pulmonary Embolism
por: Fabijanic, Damir, et al.
Publicado: (2012)

Does screening for peripheral arterial disease improve risk stratification for patients at intermediate risk for coronary artery disease?
por: Greiver, Michelle
Publicado: (2007)

Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing
por: Wang, Bianhong, et al.
Publicado: (2016)

Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)

Pulmonary embolism among critically ill patients with ARDS due to COVID-19
por: Soumagne, T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nsdkvrsrtoprkfodkl0fdc15bg